DRESS syndrome to sulfasalazine;Syndrome DRESS à la sulfasalazine

Revue Medicale de Liege

Volumn 61, Issue 9, 2006, Pages 643-648

  Bourguignon, R ^a   Pierard Franchimont C ^a,b   Paquet, P ^b   Pierard G E ^b  

^a Service de Dermatologie   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Adverse drug reaction; Cutaneous drug reaction; DRESS syndrome; Leukopenia; Liver cytolysis

Indexed keywords

ANTIHISTAMINIC AGENT; METHYLPREDNISOLONE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CYTOLYTIC HEPATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG HYPERSENSIBILITY; DRUG HYPERSENSITIVITY; HUMAN; HUMAN TISSUE; LABORATORY TEST; PRURITUS; RASH; SKIN BIOPSY; TREATMENT OUTCOME; FEMALE; SYNDROME;

ADULT; ANTIRHEUMATIC AGENTS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; SULFASALAZINE; SYNDROME;

EID: 33749618324     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bocquet H, Bagot M, Roujeau JC.- Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash With Eosinophilia and Systemic Symptoms: DRESS). Sem Cutan Med Surg, 1996, 1, 250-251.
2. Fumai I, Sriha B, Paquet P, et al.- Les toxidermies iatrogènes, une rançon de la quête de la santé. Rev Med Liège, 2001, 56, 583-591.
3. Begon E, Roujeau JC.- Syndrome d'hypersensibilité médicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann Dermatol Venereol 2004, 131, 293-297.
4. Paquet P, Flagothier C, Piérard-Frnachimont C, et al.- Les toxidermies paroxystiques graves. Rev Med Liège, 2004, 59, 286-292.
5. Paquet P, Piérard GE.- Synopsis des mécanismes pathogéniques des toxidermies graves. Dermatol Actual, 2004, 85, 22-24.
6. Roujeau JC, Stern RS- Severe adverse cutaneous reactions to drugs. N Engl J Med, 1994, 33, 1272-1285.
7. Bocquet H, Roujeau JC.- Les réactions cutanées sévères induites par des médicaments. Rev Fr Allergol Immunol Clin, 1997, 37, 654-659.
8. Callot V, Roujeau JC, Bagot M, et al.- Drug-induced pseudolymphoma and hypersensitivity syndrome, two different clinical entities. Arch Dermatol, 1996, 132, 1315-1321.
9. McKenna KE, Burrows D.- Leucopenia, thrombocytopenia and lymphadenopathy associated with sulfasalazine. Clin Exp Dermatol, 1994, 19, 419-420.
10. Tohyama M, Yahata Y, Yasukawa M, et al.- Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human Herpesvirus 6. Arch Dermatol, 1998, 134, 1113-1117.
11. Kano Y, Inaoka M, Shiohara T.- Association between anticonvulsivant hypersensitivity syndrome and human herpesvirus 6 reactivation, and hypogammaglobulinemia. Arch Dermatol, 2004, 140, 183-188.
12. Nakashima N, Yamane K, Ihn H, et al.- Drug-induced hypersensitivity syndrome associated with transient hypogammaglobulinemia and increase in serum IgE level. Dermatology, 2005, 210, 349-352.
13. Shiohara T, Kano Y.- Are viral infections responsible for the development of drug-induced hypersensitivity syndrome as well as graft-versus-host diseases? (editorial). Dermatology, 2005, 210, 255-260.
14. Kleier RS, Breneman DL, Boiko S.- Generalized postulation as a manifestation of the anticonvulsivant hypersensitivity syndrome. Arch Dermatol, 1991, 127, 1361-1364.
15. Roberts DL, Marks R.- Skin reactions to carbamazepine. Arch Dermatol, 1981, 117, 273-275.
16. Handfield-Jones SE, Jenkins RE, Whittaker SJ, Besse CP.- The anticonvulsivant hypersensitivity syndrome. Br J Dermatol, 1993, 12, 175-177.
17. Antunes A, Davril A, Moussa, et al.- Syndrome d'hypersensibilité médicamenteuse. Nouv Dermatol, 1997, 16, 198-202.
18. Tomecki KJ, Catalano CJ.- Dapsone hypersensitivity. The sulfone syndrome revisited. Arch Dermatol, 1981, 117, 38-39.
19. Gallais V, Grange F, De Bandt M, et al.- Toxidermie à la sulfasalazine. Ann Dermatol Venereol, 1994, 121, 11-14.
20. Singer JZ, Wallace SL.- The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum, 1986, 29, 82-87.
21. Alldrege BK, Knutsen AP, Ferreiro D.- Antiepileptic drug hypersensitivity syndrome : in vitro and clinical observation. Pediatr Neurol, 1994, 10, 169-171.
22. Parneix-Spake A, Bastuji-Garin S, Lobut JB, Erner J.- Minocycline as possible cause of severe and protracted hypersensibility drug reaction. Arch Dermatol, 1995, 131, 490-491.
23. Bourezane Y, Salard D, Hoen B, et al.- DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy. Clin Infect Dis, 1998, 25, 1321-1322.
24. Le Nouail P, Viseux V, Chaby G, et al.- Syndrome d'hypersensibilité médicamenteuse (DRESS) après traitement par Imatinib (Glivec*). Ann Dermatol Venereol, 2004, 131, 1S247.
25. Bernez A, Abdallah-Lotf M, Machet M, et al.- DRESS syndrome avec atteinte pulmonaire sévère, mais asymptomatique après une prise d'un medicament homéopathique. Ann Dermatol Venereol, 2004, 131, 1S249.
26. Tennis P, Stern RS.- Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine or sodium valproate: a record linkage study. Neurology. 1997, 49, 542-546.
27. Delboy H.- Les effets indésirables de l'acide 5-aminosalicylique. Gastroenterol Clin Biol, 1997, 21, 377-386.
28. Fardy JM, Llyod DA, Reynolds RPE.- Adverse effects with oral 5-aminosalicylic acid. J Clin Gastroenterol, 1988, 10, 635-637.
29. Brimblecombe R.-_ Mesalazine, a global safety evaluation. Scand J Gastroenterol, 1990, 25, 66-68.
30. Turunen U, Elomaa I, Antila VJ, Seppala K.- Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulfasalazine or sulfonamides. Scand J Gastroenterol, 1987, 22, 798-802.
31. Rao SS, Cann PA, Holdsworth CD.- Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulfasalazine. Scand J Gastroenterol, 1987, 22, 332-336.
32. Habal FM, Greenberg GR.- Treatment of ulcerative colitis with oral 5-amino salicylic acid including patients with adverse reactions to sulfasalazine. Am J Gastroenterol, 1988, 83, 15-19.
33. Gennis MA, Vemuri R, Burns EA, et al.- Familial occurrence of hypersensitivity to phenytoin. Am J Med. 1991, 91, 631-634.
34. Shear NH, Spielberg SP.- Anticonvulsivant hypersensitivity syndrome. J Clin Invest. 1988, 82, 1826-1832.
35. Wolkenstein P, Charue D, Laurent P, et al.- Metabolic predisposition to cutaneous adverse drug reactions. Arch Dermatol, 1995, 131, 544-551.
36. Picard D, Joly P, Barbaud A, et al.- Etude clinico-biologique de l'évolution de patients atteints du syndrome d'hypersensibilité médicamenteuse. Ann Dermatol Venereol, 2004, 131, 1S32.
37. Picard D, Joly P, Barbaud A, et al.- Etude du profil d'expression génique, du phénotype et de la fonctionnalité des lymphocytes T au cours du syndrome d'hypersensibilité médicamenteuse. Ann Dermatol Venereol. 2004, 131, 1S32.